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Abstract
Background: Variations in the fat mass and obesity-associated gene (FTO) are associated with obesity; however, it
is unclear if changes in energy intake affect the adaptive response to caloric restriction in those with risk variants.
The three FTO single nucleotide polymorphisms (SNPs), rs1421085, rs17817449 and rs9939609, are in strong linkage
disequilibrium. Thus, the purpose of this investigation was to determine the role of these FTO SNPs vis-à-vis the
effects of a 4-week hypocaloric diet on body composition in exercise-trained men and women. Two salivary
biomarkers that associate with energy expenditure were also assessed (cortisol and salivary alpha-amylase, sAA).
Methods: Forty-seven exercise-trained men (n = 11) and women (n = 36) (mean ± SD: age 32 ± 9 years; height
169 ± 8 cm, body mass index 24.5 ± 2.9 kg/m2, hours of aerobic training per week 4.9 ± 3.8, hours of weight
training per week 3.9 ± 2.4, years of training experience 13.4 ± 7.0) completed a 4-week hypocaloric diet (i.e.,
decrease total calories by ~ 20–25% while maintaining a protein intake of ~ 2.0 g/kg/d). Subjects were instructed to
maintain the same training regimen and to decrease energy intake via carbohydrate and/or fat restriction during
the treatment period. Body composition was assessed via dual-energy X-ray absorptiometry (DXA) (Model: Hologic
Horizon W; Hologic Inc., Danbury CT USA). Total body water was determined via a multifrequency bioelectrical
impedance (BIA) device (InBody 770). Saliva samples were collected pre and post intervention in order to genotype
the participants as well as to determine the concentrations of cortisol and sAA.
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Results: Of the 47 subjects, 15 were of normal risk for obesity whereas 32 were carriers of the FTO gene risk alleles.
Subjects were grouped based on their genotype for the three FTO SNPs (i.e., rs1421085, rs17817449 and rs9939609)
due to their strong linkage disequilibrium. We have classified those with the normal obesity risk as “non-risk allele”
versus those that carry the “risk allele” (i.e., both heterozygous and homozygous). Both groups experienced a
significant decrease in total energy intake (p < 0.01); non-risk allele: pre kcal 2081 ± 618, post kcal 1703 ± 495; risk
allele: pre kcal 1886 ± 515, post kcal 1502 ± 366). Both groups lost a significant amount of body weight (p < 0.01);
however, there was no difference between groups for the change (post minus pre) in each group (risk allele
change: − 1.0 ± 1.2 kg, non-risk allele change: − 1.2 ± 1.4 kg). Additionally, both groups lost a significant amount of
fat mass (p < 0.01) with no differences between groups for the change in fat mass (risk allele change for fat mass:
1.1 ± 0.7 kg, non-risk allele change − 0.9 ± 0.4 kg). There were no significant changes in either group for fat free
mass or total body water. The change in salivary alpha-amylase or cortisol was not different between groups.
Conclusions: In the short-term (i.e., 4 weeks), exercise-trained men and women consuming a hypocaloric diet that
is relatively high in protein experience similar changes in body composition due exclusively to a decrement in fat
mass and independent of FTO allele status. Therefore, weight and fat loss on a hypocaloric diet is, at least in the
short-term, unaffected by the FTO gene.
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Background
There are several single nucleotide polymorphisms (SNPs)
on the fat mass and obesity-associated (FTO) gene that
are associated with obesity in adults and children [1–7].
For the FTO SNP rs8050136, homozygotes for the risk al-
lele (A/A) have 1.67 times greater risk of obesity than
those who do not have the allele [8]. Furthermore, the
FTO genotype was associated with changes in body com-
position as a result of regular exercise. Thus, carriers of
the C allele showed three times greater fat mass and
percent body fat losses than the A/A homozygotes [8]. It
is unclear if the FTO genotype has an interaction with
macronutrient intake. One group tested the effects of an
FTO variant (rs1558902) on weight loss in response to
2-year diet interventions. This study demonstrated that a
high-protein diet might be beneficial for weight loss and
improvement of body composition and fat distribution in
individuals with the risk allele of the FTO variant
rs1558902 [9]. In an investigation that was comprised of
788 unrelated Mexican-Mestizo individuals, the FTO
SNPs (rs9939609, rs1421085, and rs17817449) were a
major risk factor for obesity [10]. Recent data character-
ized the FTO SNP (rs1421085), which results in a T to C
nucleotide substitution, in a cohort of exercise-trained
men and women [11]. The study population of 108 exer-
cise-trained individuals included professional mixed
martial arts fighters, competitive distance runners, collegi-
ate swimmers, stand-up paddlers as well as a cohort of
recreational bodybuilders. The data showed that C allele
carriers had significantly higher fat mass and percent body
fat relative to the TT group. However, due to the cross-
sectional nature of this investigation, it was not possible to
determine causality regarding the FTO gene and body
composition [11]. Nonetheless, it is evident that
investigations of the FTO gene focus primarily on over-
weight or obese individuals [3, 5, 12, 13]. The current
investigation is a follow up on the cross-sectional data
previously obtained from a cohort of exercise-trained indi-
viduals [11]. Certainly, the cross-sectional data shows that
the presence of the risk variant for the FTO gene is associ-
ated with an elevated fat mass. However, one cannot
assign causality based on observational data. Thus, the
purpose of this investigation was to determine if body
composition was differentially altered in a group of exer-
cise-trained men and women based on their FTO geno-
type. This is the first investigation in exercise-trained men
and women that have examine the role of the FTO SNPs
as it relates to caloric restriction and body composition as-
sessment. The FTO SNPs (rs9939609, rs1421085, and
rs17817449) were analyzed due to their strong linkage dis-
equilibrium (i.e., there is a non-random association of al-
lele types in these SNPs).
Methods
Participants
Subjects came to the laboratory on two occasions for body
composition assessment and to provide saliva samples. In
accordance with the Helsinki Declaration, the University’s
Institutional Review Board approved all procedures that
involved human subjects. Written informed consent was
obtained prior to participation. In order to control for the
circadian influence on cortisol, all testing took place be-
tween 1130 and 1400. Participants were instructed not to
exercise, eat, or drink anything other than water 3 h prior
to testing. For the duration of the 4-week treatment
period, subjects were instructed as well to not alter their
training regimen substantially.
Antonio et al. Journal of the International Society of Sports Nutrition           (2019) 16:36 Page 2 of 9
Body composition
Subjects had their body composition assessed via dual-
energy X-ray absorptiometry (DXA) (Model: Hologic
Horizon W; Hologic Inc., Danbury CT USA). Quality
control calibration procedures were performed on a
spine phantom. Subjects wore typical athletic clothing
and removed all metal jewelry. They were positioned
supine on the DXA within the borders delineated by the
scanning table. Each whole body scan took approxi-
mately 7 min. In addition, total body water was deter-
mined via bioelectrical impedance (Model: InBody 770,
Cerritos, California USA). Subjects stood on the plat-
form of the device barefoot with the soles of their feet
on the electrodes. Subjects then grasped the handles of
the unit with their thumb and fingers to maintain direct
contact with the electrodes. They stood still for ~ 1 min
while maintaining their elbows fully extended and their
shoulder joint abducted to about a 30 degree angle.
Food diary
Subjects kept a diary (i.e., ~3 days per week) of their food
intake via a smartphone app (MyFitnessPal®). The use of
mobile apps for dietary self-reporting has been previously
reported [14]. Every subject had previously used this mo-
bile app. The MyFitnessPal® app is a database comprised
of over 5 million foods that have been provided by users
via entering data manually or by scanning the bar code on
packaged goods. Thus, the data themselves are primarily
derived from food labels (i.e., Nutrition Facts Panel) de-
rived from the USDA National Nutrient database. Subjects
were instructed to decrease their food intake by ~ 20–25%
while maintaining a relatively high protein intake (~ 2 g
per kilogram body weight daily). Thus, subjects decreased
their carbohydrate and fat intake to promote a energy
deficit.
Genotyping
Genomic DNA was extracted in a QIAcube instrument
following the manufacturer’s standard protocol for saliva
nucleic acid extraction (QIAGEN, Valencia, CA). After
isolation, allelic discrimination for the three FTO SNPs
was determined via real-time polymerase chain reaction
(PCR) using TaqMan SNP genotyping assays using fluoro-
genic probes (Applied Biosystems, CA) with the following
primer sequences.
rs1421085:
TAGCAGTTCAGGTCCTAAGGCATGA[C/T]ATTG
ATTAAGTGTCTGATGAGAATT, rs17817449: GTG
TTTCAGCTTGGCACACAGAAAC[G/T]GTTTTAA
TTTAACAGTCCAGCTCCT, rs9939609: GGTTCCT
TGCGACTGCTGTGAATTT[A/T]GTGATGCACTT
GGATAGTCTCTGTT.
For all three genotyping assays, thermal cycling was per-
formed on StepOne Real-Time PCR system (Applied
Biosystems, CA). The amplification mix contained the fol-
lowing ingredients: 12.5 μL of PCR master mix (QIAGEN,
Valencia, CA), 1.25 μL of TaqMan 20X working stock,
10.25 μL of RNase- and DNase-free water (Sigma), and
1.0 μL of sample DNA, in a total volume of 25 μL per sin-
gle tube reaction. The PCR conditions were 95 °C for 10
min followed by 40 repeated cycles of 95 °C for 15 s and
60 °C for 60 s. Genotypes were determined automatically
via the StepOne software (Applied Biosystems, CA) based
on the fluorescence signals. Samples were run in duplicate
and in the case of a call discrepancy, samples were rerun.
It is known that the three FTO SNPs that we exam-
ined (i.e., rs1421085, rs17817449 and rs9939609) are in
strong linkage disequilibrium. Each SNP is briefly
described in Table 3 [1, 11, 15, 16]. Thus, we have classi-
fied those with the normal obesity risk as “non-risk
allele” versus those that carry the “risk allele” (i.e., both
heterozygous and homozygous).
Salivary cortisol and alpha-amylase
At each testing session the participants provided saliva
samples for sAA and cortisol quantification. An additional
saliva sample was collected at baseline for genotyping.
Saliva was collected from each participant by unstimulated
passive salivate. Immediately after collection, sample tubes
were stored in a − 20 °C freezer, and later quantified via
human enzyme immunoassay kits per the manufacturer’s
instructions (Salimetrics LLC, USA).
Cortisol
Saliva samples were run in duplicate and quantified via a
human cortisol enzyme immunoassay (EIA) kit per the
manufacturer’s instructions (Salimetrics LLC, USA). The
samples were immediately read in a BioTek ELx800 plate
reader (BioTek Instruments, Inc., USA) at 450 nm with a
correction at 630 nm. All samples were within the detec-
tion ranges indicated in the cortisol immunoassay kit, and
the variations of sample readings were within the expected
limits. Final concentrations for the biomarkers were gen-
erated by interpolation from the standard curve in μg/dL.
Salivary alpha amylase (sAA)
Saliva samples were run in duplicate and quantified via a
human Kinetic Enzyme Assay Kit per the manufacturer’s
instructions (Salimetrics LLC, USA). The samples were
immediately read in a BioTek ELx800 plate reader
(BioTek Instruments, Inc., USA) at 405 nm. All samples
were within the detection ranges indicated in the assay kit,
and the variations of sample readings were within the
expected limits. Final concentrations for the biomarkers
were generated via absorptivity over 2min and generated
in U/mL of activity.
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Statistical analysis
All data are presented as the mean ± SD (standard devi-
ation). A series of paired (pre vs post) and unpaired
(delta score between groups) t-tests were used to assess
the relationship between FTO genotype (risk versus
non-risk allele) and body composition, diet, and salivary
biomarkers. The distribution of allele frequencies was
determined by the Hardy–Weinberg Exact (HWE) test,
and the association of allele status was analyzed using
the chi-square test. All reported p-values are two-tailed
with a priori significance level of p < 0.05. (GraphPad
Prism 6).
Results
Of the 73 initial subjects that volunteered for the investi-
gation, 10 dropped out (i.e., did not show up for post-test-
ing) and 16 were non-compliant (i.e., did not decrease
energy intake). Of the 47 compliant subjects, 15 were of
normal risk for obesity whereas 32 were carriers of the risk
alleles for the FTO gene (Tables 1, 2 and 3). The HWE
test for rs17817449 was χ2 = 0.03, p = 0.86 and rs9939609
was χ2 = 0.81, p = 0.37, suggesting that the population is
consistent with Hardy-Weinberg Equilibrium. The HWE
test for rs1421085 was χ2 = 4.02, p = 0.04. This was due to
a higher number of observed vs. expected heterozygotes
(29 vs. 22). Subjects were grouped based on their geno-
type. Both groups decreased total energy intake signifi-
cantly (~ 400 kcal) with no difference between groups
(Table 4). The decrease in energy intake was due to a
significant decrease in carbohydrate (~ 70 g) and fat
consumption (~ 20 g); however, total protein intake did
not change (Table 4).
Both the risk and non-risk allele groups experienced a
significant decrease in body weight, fat mass, % body fat,
trunk fat mass, and lower extremity fat mass (Tables 5
and 6); however, only the risk allele group experienced a
significant decline in upper extremity fat mass (Table 6).
There were no differences between groups for any of the
body composition measures (Figs. 1, 2, 3 and 4; Tables 5
and 6) except percent body fat (Fig. 5).
There was a significant increase in sAA, a marker of
sympathetic nervous system (SNS) activity, in the risk
allele group [17]; however, there were no between-group
differences for the change in sAA. Moreover, there were
no significant changes in salivary cortisol (Table 7).
Discussion
To the authors’ knowledge, this is the first randomized
controlled trial on the FTO gene that has examined the
effect of caloric restriction on a group of normal weight
men and women with several years of regular exercise
training. The data from the current investigation demon-
strates that the restriction of dietary energy from carbohy-
drate and fat result in a similar loss of fat mass in the risk
versus non-risk allele groups. Interestingly, the change in
percent body fat was significantly greater in the risk allele
(− 1.3%) versus non-risk allele (− 0.8%) group. Though not
significantly different, the risk allele group lost 1.1 kg of fat
mass compared to 0.9 kg in the non-risk allele group. Both
groups lost most of their fat mass from the trunk followed
by the lower and upper extremities. In essence, it is clear
that short-term energy restriction is effective regard-
less of whether one carries the ns for the three FTO
SNPs that we examined. Although not significant, the
risk allele group trended towards greater alterations
in body composition.
The current investigation is a follow-up to the cross-
sectional study conducted on 108 highly trained individ-
uals that included professional mixed martial arts
fighters, competitive distance runners, collegiate swim-
mers, stand-up paddlers, and recreational bodybuilders.
In that prior investigation, it was found that C allele
Table 1 Genotype
SNP Genotype Description
rs1421085 TT Normal risk
C/− In exercise-trained men and women, those
carrying the risk C allele had a significantly
higher fat mass and % body
fat [11]. This SNP is most likely risk variant
showing the highest association with
obesity [1, 11].
rs17817449 TT Normal risk
G/− This SNP is associated with body mass index,
weight and waist circumference [16].
rs9939609 TT Normal risk
A/− This SNP is associated with diminished satiety
[16].
Those who are AT or AA consumed between
125 and 280 kcal more each day than those
with the protective
TT genotype [7]; however, energy
expenditure is not affected.
Table 2 Physical characteristics and training history
Risk Allele
(n = 32),
7 males
Non-Risk
Allele
(n = 15),
4 males
Age (years) 34 ± 9 28 ± 9
Height (centimeters) 167 ± 7 173 ± 9
Body Weight (kilograms) 68.5 ± 12.5 73.9 ± 12.8
Body Mass Index (kilograms/meter2) 24 ± 3 24 ± 3
Hours of Aerobic Training Per Week 5.2 ± 4.5 4.8 ± 3.0
Hours of Resistance Training Per Week 4.2 ± 2.8 3.9 ± 1.0
Total Number of Years Training 14.7 ± 8.1 11.8 ± 4.5
Data are expressed as the mean ± SD. There were no differences between
groups. If an individual carried the risk alleles for at least two of the three
SNPs (i.e., rs1421085, rs17817449, rs9939609) they were classified as part of
the Risk Allele group
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carriers of the FTO SNP rs1421085 had significantly
higher fat mass and percent body fat versus the TT
group. Interestingly, cortisol levels were significantly
higher in the TT group relative to the C allele carriers
thus demonstrating that resting cortisol is unrelated to
body fat mass [11]. In a large-scale cross-sectional study
of 846 healthy Finnish males of Caucasian origin,
subjects were genotyped for the FTO SNP rs8050136.
The AA genotype of the FTO SNP rs8050136 is associated
with a higher BMI and greater waist circumference com-
pared to the genotype CC. It was discovered that there
was no relationship between the FTO gene and aerobic or
neuromuscular exercise performance. Thus, aerobic fit-
ness may not modify the effect of FTO variation on body
composition traits [18]. Another group investigated
whether body composition and metabolism were modu-
lated by the FTO SNP rs9939609 in a group of young
women engaged in exercise training. A group of 201
young Polish women were examined before and after the
completion of a 12-week training program. Subjects with
AA and AT genotypes had higher BMI during the entire
Table 3 Baseline characteristics according to FTO genotype for the three SNPs
FTO SNP Genotype Age
(yr)
Sex n (m/f) Height
(cm)
Body Weight
(kg)
Body Fat %
rs1421085 TT 28 ± 10 6/8 174 ± 8 76.1 ± 11.1 26.7 ± 7.2
CT + CC 34 ± 9 6/27 167 ± 7 67.7 ± 12.5 26.4 ± 5.8
rs17817499 TT 28 ± 10 5/11 173 ± 9 73.6 ± 12.8 26.2 ± 7.4
GT + GG 34 ± 8 6/25 167 ± 7 68.4 ± 12.6 26.8 ± 5.7
rs9939609 TT 27 ± 10 4/10 173 ± 9 73.8 ± 12.7 27.1 ± 7.0
AT + AA 34 ± 9 8/25 168 ± 7 68.7 ± 12.4 26.2 ± 5.9
Data are expressed as the mean ± SD. Legend: cm Centimeters, f Female, kg Kilograms, m Male, yr Years of age. Note: we grouped heterozygotes/homozygotes
that were at increased risk for obesity for all three SNPs (i.e., C/−, G/− and A/−)
Table 4 Nutrition
Risk Allele Non-Risk Allele
Pre-kcal 1868 ± 477 2081 ± 618
Post-kcal 1465 ± 346* 1703 ± 495*
Change (kcal) − 403 ± 280 − 378 ± 308
Pre-kcal/kg/d 27.4 ± 6.3 28.6 ± 8.9
Post-kcal/kg/d 21.7 ± 4.1* 23.8 ± 7.5*
Change (kcal/kg/d) −5.7 ± 4.0 −4.9 ± 4.4
Pre-carbohydrate (grams) 190 ± 60 227 ± 88
Post-carbohydrate (grams) 129 ± 58* 154 ± 72*
Change (grams) −67 ± 50 −74 ± 42
Pre-carbohydrate (g/kg/d) 2.8 ± 0.8 3.2 ± 1.4
Post-carbohydrate (g/kg/d) 1.8 ± 0.6* 2.2 ± 1.2
Change (g/kg/d) −1.0 ± 0.7 −1.0 ± 0.6
Pre-protein (grams) 130 ± 51 131 ± 42
Post-protein (grams) 142 ± 41# 143 ± 48
Change (grams) 12 ± 30 12 ± 44
Pre-protein (g/kg/d) 1.9 ± 0.7 1.8 ± 0.5
Post-protein (g/kg/d) 2.1 ± 0.6# 2.0 ± 0.6
Change (g/kg/d) 0.2 ± 0.4 0.2 ± 0.6
Pre-fat (grams) 67 ± 24 72 ± 23
Post-fat (grams) 47 ± 15* 58 ± 20*
Change (grams) −21 ± 14 −15 ± 11
Pre-fat (g/kg/d) 1.0 ± 0.3 1.0 ± 0.3
Post-fat (g/kg/d) 0.7 ± 0.2* 0.8 ± 0.2*
Change (g/kg/d) −0.3 ± 0.2 −0.2 ± 0.2
Date are mean ± SD. Legend – d Day, g Grams, kcal Kilocalories, kg Kilograms
*p < 0.01 Post versus Pre
#p < 0.05 Post versus Pre
There were no differences between groups for the change
Table 5 Body composition
Risk Allele Non-Risk Allele
Pre-body weight (kg) 68.7 ± 12.6 73.6 ± 12.8
Post-body weight (kg) 67.7 ± 12.5* 72.4 ± 12.3*
Change (kg) −1.0 ± 1.2 − 1.2 ± 1.4
Pre-fat free mass (kg) 47.8 ± 9.2 51.5 ± 10.7
Post-fat free mass (kg) 47.9 ± 9.1 51.2 ± 10.4
Change (kg) 0.1 ± 1.0 − 0.3 ± 1.3
Pre-fat mass (kg) 18.2 ± 6.1 19.3 ± 6.1
Post-fat mass (kg) 17.1 ± 6.1* 18.4 ± 6.0*
Change (kg) −1.1 ± 0.7 −0.9 ± 0.4
Pre-body fat % 26.5 ± 5.8 26.2 ± 7.4
Post-body fat % 25.2 ± 5.8* 25.4 ± 7.5*
Change −1.3 ± 1.0** −0.8 ± 0.7
Pre-bone mineral content (kg) 2.6 ± 0.5 2.9 ± 0.5
Post-bone mineral content (kg) 2.6 ± 0.5 2.9 ± 0.5
Change (kg) 0.0 ± 0.1 0.0 ± 0.1
Pre-total body water (liters) 38.8 ± 7.8 42.2 ± 8.4
Post-total body water (liters) 39.1 ± 7.6 42.1 ± 8.1
Change (liters) 0.3 ± 0.9 −0.1 ± 1.0
Data are expressed as the mean ± SD. Legend: kg Kilogram
*p < 0.01 post versus pre within groups. There were no between-group
differences except for the change in % body fat.**
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study period compared with the TT genotype. Although
BMI, basal metabolic rate, percent body fat, fat mass, fat-
free mass, total body water, high-density lipoprotein, and
glucose changed significantly during the training program,
there were no differences between groups (i.e., those with
the risk alleles, AA and AT, responded similarly as those
that were the TT genotype) [19]. This further demon-
strates that given the same exercise intervention, the
adaptive response is similar between risk and non-risk
allele groups.
According to Harbron et al. the risk alleles of the FTO
polymorphisms were associated with poorer eating be-
haviors (e.g., higher hunger, internal locus for hunger,
and emotional disinhibition scores), as well as a higher
intake of high fat foods and refined starches and more
depressive symptoms [4]. It has been suggested that spe-
cific macronutrient diet composition can influence the
adaptive response as it relates to the FTO gene. Thus, it
would seem plausible that dietary habits can modify the
FTO gene risk allele influence on obesity [20]. For
instance, in adolescents whose fat intake was below 30%,
the A allele of rs9939609 was not associated with adipos-
ity. Conversely, adolescents whose fat intake was
between 30 and 35% of energy, the rs9939609 SNP was
associated with a 1.9% higher body fat per risk allele and
in those whose fat intake was higher than 35%, it was
associated with a 2.8% higher body fat per risk allele. At
least with this specific FTO SNP rs9939609, adiposity
may be exacerbated in adolescents consuming high fat
diets [21]. The current investigation showed that a
decrease in energy consumption (~ 5–6 kcal/kg/day
decrease) resulted in a fat mass loss with no change in
fat-free mass. Our subjects consumed a relatively high
protein diet (~ 2 g/kg/d) during the 4-week treatment. It
is likely that the maintenance of fat-free mass during
caloric restriction was due both to the high protein
intake as well as the ~ 9 h per week of exercise training
Table 6 Segmental fat mass changes
Risk Allele Non-Risk Allele
Pre-trunk fat mass (kg) 7.6 ± 2.9 8.0 ± 3.2
Post-trunk fat mass (kg) 6.8 ± 2.7* 7.5 ± 3.1*
Change (kg) −0.7 ± 0.6 − 0.5 ± 0.3
Pre-upper extremity fat mass (kg) 2.1 ± 0.8 2.4 ± 0.8
Post-upper extremity fat mass (kg) 2.0 ± 0.7* 2.3 ± 0.9
Change (kg) −0.1 ± 0.3 −0.1 ± 0.3
Pre-lower extremity fat mass (kg) 7.3 ± 3.2 7.8 ± 2.3
Post-lower extremity fat mass (kg) 7.1 ± 3.3# 7.6 ± 2.4#
Change (kg) −0.2 ± 0.3 −0.2 ± 0.4
Date are expressed as the mean ± SD. Legend: kg Kilogram
*p < 0.01 post versus pre
#p < 0.05 post versus pre
There were no differences between groups for the change
Fig. 1 The change in body weight (post weight minus pre weight).
There were no between-group differences. Data are expressed as
the mean ± SD
Fig. 2 The change in fat mass (post fat mass minus pre fat mass).
There were no between-group differences. Data are expressed as
the mean ± SD
Fig. 3 The change in fat-free mass (post fat-free mass minus pre fat-
free mass). Fat-free mass did not change in either group. There were
no between-group differences. Data are expressed as the mean ± SD
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this cohort of subjects performed. Di Renzo et al. studied
a group of 188 Italian subjects to determine the effects
of a Mediterranean diet on body composition during a
4-week treatment. The FTO SNP rs9939609 was deter-
mined in this cohort. They discovered that although the
diet reduced fat mass, the FTO genotype had no influ-
ence on the loss of fat mass [22]. Hubacek et al. analyzed
the FTO SNP rs17817449 in 6024 adults aged 45–69
years to assess the role of diet and physical activity. This
FTO variant was significantly associated with body mass
index and basal metabolic rate; on the other hand, it was
not associated with physical activity, total energy intake or
with energy intakes from fat, carbohydrates, proteins or
alcohol [23]. Zhang et al. conducted the most extensive
study to date on the influence of a dietary intervention in
obese adults and the FTO SNP rs1558902 [9]. The FTO
SNP rs1558902 was genotyped in 742 obese adults who
were randomly assigned to one of four diets differing in
the proportions of fat, protein, and carbohydrate: the tar-
get percentages of energy derived from fat, protein, and
carbohydrate in the four diets were 20, 15, and 65%; 20,
25, and 55%; 40, 15, and 45%; and 40, 25, and 35%. Body
composition and fat distribution were measured by dual-
energy x-ray absorptiometry and computed tomography.
They discovered that carriers of the rs15589002 risk allele
(A) had a greater reduction in weight, body composition,
and fat distribution in response to a high-protein diet,
whereas an opposite genetic effect was observed on
changes in fat distribution in response to a low-protein
diet. This data suggest that a higher protein diet may be
beneficial for body composition those with the risk allele
of the FTO variant rs1558902 [9]. Certainly at this point,
it is unclear how diet and the FTO gene interact. How-
ever, based on the limited number of randomized
controlled trials, it is evident that caloric restriction can
produce a loss of fat mass regardless of one’s FTO
genotype.
An association between an FTO SNP and cortisol
levels was previously reported in a cross-sectional study
of exercise-trained individuals where the non-risk allele
group had higher cortisol levels [11]. Additionally, there
is an association between high cortisol levels and obesity
[24]. However, the current investigation found no
change in cortisol (post minus pre) in either group. Also,
despite the fact that sAA increased in the risk allele
group, the differences between the groups (change in
sAA) were no significantly different. Thus, it is not clear
what relationship cortisol or sAA has with the FTO gene
and changes in body composition in exercise-trained
individuals.
Limitations and future directions
Although we did not find any differences in body com-
position changes between subjects that were of normal
risk versus those that carried the risk alleles for the FTO
gene, it should be noted that our study was fairly short-
Fig. 4 The change in percent body fat (post % body fat minus pre
% body fat). The Risk Allele group experienced a greater change in
% body fat versus the Non-Risk Allele group (p < 0.05). Data are
expressed as the mean ± SD
Fig. 5 The change in total body water (post total body water minus
pre total body water). There weas no change in total body water.
There were no between-group differences. Data are expressed as
the mean ± SD
Table 7 Biomarkers
Risk Allele Non-Risk Allele
Pre-sAA (U/mL) 90.7 ± 71.8 98.2 ± 77.1
Post-sAA (U/mL) 132.0 ± 116.4# 113.3 ± 67.5
Change (U/mL) 42.1 ± 104.4 15.0 ± 63.3
Pre-cortisol (micrograms/dL) 0.259 ± 0.181 0.221 ± 0.134
Post-cortisol (micrograms/dL) 0.163 ± 0.181 0.213 ± 0.182
Change (micrograms/dL) −0.097 ± 0.275 − 0.008 ± 0.158
Data are mean ± SD. Legend: dL Deciliter, mL Milliliter, sAA
Salivary alpha-amylase
#p < 0.05 Post versus Pre. There were no between group differences for the
change in sAA or cortisol
Antonio et al. Journal of the International Society of Sports Nutrition           (2019) 16:36 Page 7 of 9
term (i.e., 4 weeks) and a longer treatment duration may
have resulted in a different outcome. Moreover, it would
be intriguing to assess whether protein overfeeding
would result in a different body composition response in
those that carry the risk variants.
Conclusion
Exercise-trained men and women that carry the risk al-
leles for the FTO SNPs (rs1421085, rs17817449 and
rs9939609) had similar changes in body composition
compared to those at normal risk after a 4-week period
of energy restriction. The decrease in percent body fat
was due exclusively to a loss of fat mass. Total body
water did not change in either group; thus, we can rule
out a decrease in percent body fat due to an elevation of
total body water. At least in the short-term, individuals
can lose fat mass in spite of their FTO genotype. Thus
one can conclude that changes in body composition are
unaffected by the FTO gene (i.e., energy restriction will
produce a loss of fat mass whether one has the risk or
non-risk alleles).
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